Brief: JW Pharmaceutical lowers conversion price of 2th and 3th series convertible bonds to 45,068 won/share
06/03/2017 09:39
March 6 (Reuters) - JW Pharmaceutical 001060.KS :
* Says it lowered conversion price of 2th and 3th series
preferred convertible bonds to 45,068 won/share from 57,158
won/share, effective March 7
Source text in Korean: https://goo.gl/UMRRqB
Further company coverage: 001060.KS
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +86 010 62674724;
Reuters Messaging: hedy.cui.reuters.com@reuters.net))
Recent news on JW Pharmaceutical
See all newsBrief: Jw Pharmaceutical Q3 Operating Profit 32.6 Billion Won, Up 24% From Year Earlier
Brief: Jw Pharmaceutical Q2 Operating Profit 25.4 Billion Won, Up 103.3% From Year Earlier
Brief: Jw Pharmaceutical Q1 Operating Profit 22.6 Billion Won, Down 15.4% From Year Earlier
Brief: Jw Pharmaceutical To Acquire 5 Billion Won Worth Of Own Shares
Brief: Jw Pharmaceutical To Acquire 5 Billion Won Worth Of Own Shares